Pilot Study of Bone Biopsy and Aspirate in Women With Metastatic Breast Cancer
NCT ID: NCT01975597
Last Updated: 2023-09-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
8 participants
OBSERVATIONAL
2013-08-31
2014-11-19
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Lymph Fluid and Blood Collection for Identification of Novel Biomarkers
NCT01075607
Enabling the Study of Metabolism in Breast Cancer Through Collection of Fresh-tissue Biopsies
NCT03880097
Tissue Procurement Protocol for Patients Undergoing Treatment for Early-Stage Breast Cancer
NCT02455882
Prognostic Study of Sentinel Lymph Node and Bone Marrow Metastases in Women With Stage I or Stage IIA Breast Cancer
NCT00003854
Diagnostic Procedures in Detecting Tumor Cells in the Bone Marrow of Patients Undergoing Surgery for Stage I, Stage II, or Stage IIIA Breast Cancer
NCT00089323
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Bone marrow aspirates and biopsy
Bone marrow aspirates and biopsy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Bone marrow aspirates and biopsy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients willing and able to provide informed consent \& perform study procedures
* Patients may enroll with recently (with 2 months) progressive tumor burden
* Performance status of 0,1 or 2
Exclusion Criteria
* Patients with active, uncontrolled coagulopathy
* Patients on treatment dose anticoagulation or an International Normalised Ratio of 2 or greater if on warfarin
* Patients who are known to be pregnant are not eligible to participate in this study during the time of the pregnancy
21 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Michigan Rogel Cancer Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Catherine Van Poznak, MD
Role: PRINCIPAL_INVESTIGATOR
University of Michigan Rogel Cancer Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Michigan
Ann Arbor, Michigan, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HUM00075575
Identifier Type: OTHER
Identifier Source: secondary_id
UMCC 2013.053
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.